Clinical Trials Directory

Trials / Sponsors / Biohaven Therapeutics Ltd.

Biohaven Therapeutics Ltd.

Industry · 17 registered clinical trials — 9 currently recruiting.

StatusTrialPhaseStarted
Enrolling By InvitationA Phase 1b Study of BHV-7000 in Participants With Inherited Erythromelalgia
Familial Erythromelalgia
Phase 12026-01-15
Active Not RecruitingTaldefgrobep Alfa in Adults With Overweight and Obesity
Obesity, Overweight
Phase 22025-11-24
RecruitingStudy of BHV-1300 in Graves' Disease
Graves Disease
Phase 12025-08-21
RecruitingStudy of BHV-1400 in IgA Nephropathy
IgA Nephropathy
Phase 12025-07-30
RecruitingA Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early
Parkinson Disease
Phase 2 / Phase 32025-05-28
RecruitingA Phase 1 Study of BHV-1530 in Advanced Solid Tumors
Solid Tumor
Phase 12025-03-20
CompletedEfficacy and Safety Trial of BHV-2100 for the Acute Treatment of Migraine
Migraine
Phase 22024-10-10
CompletedLong-term Safety Study of BHV-7000 in Participants With Major Depressive Disorder (MDD)
Major Depressive Disorder
Phase 22024-08-01
Enrolling By InvitationLong-term Safety and Tolerability of BHV-7000
Focal Epilepsy
Phase 22024-07-30
TerminatedBHV-7000 Open-Label Extension Bipolar Mania Study
Bipolar Disorder
Phase 22024-06-24
TerminatedA Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Gen
Generalized Epilepsy
Phase 2 / Phase 32024-06-20
CompletedBHV-7000 Acute Treatment of Bipolar Mania
Bipolar Disorder
Phase 2 / Phase 32024-05-28
CompletedEfficacy and Safety Study of BHV-7000 Monotherapy in Major Depression
Major Depressive Disorder
Phase 22024-05-28
RecruitingStudy to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
Focal Epilepsy
Phase 2 / Phase 32024-05-13
RecruitingA Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors
Solid Tumor
Phase 1 / Phase 22024-04-22
RecruitingA Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
Focal Epilepsy
Phase 2 / Phase 32024-03-14
Active Not RecruitingReal-World Data Study of Troriluzole-Treated Patients With Spinocerebellar Ataxia (SCA) Compared to a Matched
Spinocerebellar Ataxias
—2019-03-18